Results

Total Results: 1,881 records

Showing results for "group".

81. Kidney-Stones-Draft-Appendi-C (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
    January 01, 2024 - : 237 +- 120; Placebo group: 275 +- 131 Hyperoxaluria Baseline urinary oxalate (mg/d): KMg-citrate group … KMg-citrate group: 722 +- 229; Placebo group: 695 +- 227 Hypocitriuria Baseline urinary citrate (mg/d … ): KMg-citrate group: 587 +- 374; Placebo group: 549 +- 280 Hypomagnesuria Baseline urinary magnesium … (mg/d): KMg-citrate group: 116 +- 444; Placebo group: 121 +- 47 NA NA NA NA Fernandez-Rodriguez, 2006 … (p<0.01 or p<0.001 depending on timepoint); no change in the control group or HFD group Fiber intake

82. Asthma-Treatment Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_executive.pdf
    May 01, 2011 - Included trials used a control group or comparison with another breathing training technique. … .21 No group differences were reported for asthma symptoms or quality of life. … The five trials (n=360) that compared a yoga group with a control group generally showed improvements … at 12 weeks, compared with a 6 percent reduction in symptoms in the meditation group. … All four trials in this group reported on change in FEV1 (Table A).21,23,24,29 No trial found group

83. What do we know about how evidence of harm and benefit is communicated in other countries? (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
    January 01, 2005 - Canada (2002) Osteoporosis Canada Website, “Drug Treatments” New Zealand New Zealand Guidelines Group—Hormone … Women Australia and United Kingdom Australia Australian Acute Musculoskeletal Pain Guidelines Group—Evidence-based … format, Table of bisphos-phonates Not discussed New Zealand The New Zealand Guidelines Group … (extensive info on WHI) Australia Australian Acute Musculoskeletal Pain Guidelines Group … clinician guide also available Australian Acute Musculoskeletal Pain Guidelines Group

84. MEDICAL MANAGEMENT OF CONGESTIVE HEART FAILURE AND THE EFFECTIVENESS OF ISOSORBIDE DINITRATE AND HYDRALAZINE (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
    March 01, 2010 - Patients prescribed hydralazine, but not ISDN, and vice versa were included in the control group. … renal failure was present in 24.8% of the H-ISDN group, but only 8.3% of the no H-ISDN group. … Death occurred more frequently in the H-ISDN group (46.7%) than in the no H-ISDN group (35.5%). … group (18.5%). … Trandolapril Cardiac Evaluation (TRACE) Study Group [see comments].

85. Hepatitis-C-Treatment-Adherence Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_executive.pdf
    September 22, 2011 - the control group. … as opposed to 25 percent (2/8) of patients in the self-administration group. … group. … and p<0.01 for activity score) than the ribavirin-reduction comparison group. … We summarize this information by outcome and intervention group in narrative below.

86. Disclosure Policy and Form (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-ki-tep-confidentiality-form.pdf
    August 01, 2020 - EPCs generally gather Key Informant and Technical Expert input through group calls of 5-9 individuals … Although the EPC will consider all input, the purpose of the calls is not to achieve group consensus … EPCs generally gather Key Informant and Technical Expert input through group calls of 5-9 individuals … Although the EPC will consider all input, the purpose of the calls is not to achieve group consensus.

87. Pharmacologic and Nonpharmacologic Treatments of Posttraumatic Stress Disorder (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-repository-expanded-protocol.pdf
    October 24, 2019 - Indicate if treatment includes group therapy (Y/N) p. … Between-group effect size for primary PTSD outcome i. … Between-group effect sizes for all reported anxiety outcomes n. … Between-group effect sizes for all reported sleep outcomes o. … Between-group effect sizes for all reported anger outcomes p.

88. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD Repository (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol-2021_0.pdf
    January 01, 2021 - Indicate if treatment includes group therapy (Y/N) p. … Between-group effect size for primary PTSD outcome i. … Between-group effect sizes for all reported anxiety outcomes n. … Between-group effect sizes for all reported sleep outcomes o. … Between-group effect sizes for all reported anger outcomes p.

89. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD Repository Evidence Base (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd4-final-protocol.pdf
    October 01, 2022 - Indicate if treatment includes group therapy (Y/N) p. … Between-group effect size for primary PTSD outcome i. … Between-group effect sizes for all reported anxiety outcomes n. … Between-group effect sizes for all reported sleep outcomes o. … Between-group effect sizes for all reported anger outcomes p.

90. Carbohydrate-Intake-Prepub-Final-Research-Table-Rct (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-prepub-final-research-table-rct.xlsx
    May 29, 2025 - For yes: Key is person doing enrollment cannot guess what group the person will be assigned to; centralized … allocation For yes: states analysts were blinded to patient allocation For yes: overall <20% For yes: per group

91. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
    March 01, 2013 - , 85% of adalimumab group, and 95% of combo group. … , 9% of adalimumab group, and 7% of combination group had alanine aminotransferase or aspartate aminotransferase … . 46% of combo group had treatment related adverse event, compared to 24% of MTX group. … , 85% of adalimumab group, and 95% of combo group. … CYC group, 9% of adalimumab group, and 7% of combination group had alanine aminotransferase or

92. Can Physical Activity Improve the Health of Wheelchair Users? Amended Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-users-amended-protocol.pdf
    June 21, 2019 - What other research methodologies (control/comparison group design, length of intervention, research … TI random* or TI control* or TI trial or TI cohort or TI group* or TI arm* 20. … AB random* or AB control* or AB trial or AB cohort or AB group* or AB arm* 21. S19 OR S20 22. … TI random* or TI control* or TI trial or TI cohort or TI group* or TI arm* 20. … AB random* or AB control* or AB trial or AB cohort or AB group* or AB arm* 21. S19 OR S20 22.

93. Quantitative Synthesis: Chapter 2. Presenting Different Effects for Different Data Types (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-2.pdf
    February 01, 2018 - Example binary data for effect size computation Treatment Events in Treatment Group Treatment n … Events in Control Group Control n Study X 5 25 6 25 Study Y 23 194 21 189 • Ideally, the data … Where: mT = mean of treatment group mC = mean of control group Spooled = pooled standard error 5. … divided by the mean of the control group. ► Interpreted as the percentage change in outcome in the … treatment group as compared to control

94. Lumbar-Fusion-Draft-Report-Appendix-D (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-draft-report-appendix-d.xlsx
    January 01, 2019 - Group 2 vs. … 1: 0 Group 2: 1 Group 3: 0 Dura puncture, n Group 1: 2 Group 2: 1 Group 3: 0 Postoperative Severe Back … Pain, n Group 1: 0 Group 2: 0 Group 3: 1 NR 959 1 Ulrich, 2022 NA NRSI Switzerland Multiple (8) NR/ … 1: NR, 10, 27, 63, NR Group 2: NR, 13, 20, 67, NR Group 3: NR, 10, 20, 70, NR Group 4: NR, 17, 20, 63 … , S3, S4, S5) Group 1: 83.4, 13.3, 3.3, NR, NR Group 2: 80, 16.7, 3.3, NR, NR Group 3: 83.4, 10, 6.6,

95. Prognostic Tests (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-prognostic.ppt
    June 01, 2012 - Looking across the “Patients in prognostic group” row of the original low-risk group, you can see that … Looking across the “Patients in prognostic group” row of the original high risk group, 100 (25% in the … probability group. … into a lower probability group. … minus the proportion reclassified into the higher-risk group.

96. Prognostic Tests (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-prognostic.ppt
    June 01, 2012 - Looking across the “Patients in prognostic group” row of the original low-risk group, you can see that … Looking across the “Patients in prognostic group” row of the original high risk group, 100 (25% in the … probability group. … into a lower probability group. … minus the proportion reclassified into the higher-risk group.

97. Disposition of Comments_Comparative Effectiveness Review No. 245: Breast Reconstruction After Mastectomy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-disposition-comments.pdf
    October 01, 2021 - We thank the reviewers from the Breast Implant Working Group for their comments. … July 14, 2021 4 Commenter & Affiliation Section Comment Response Breast Implant Working Group … Breast Implant Working Group General In general, negative outcomes of reconstructive procedures … July 14, 2021 5 Commenter & Affiliation Section Comment Response Breast Implant Working Group … Breast Implant Working Group Introduction Instead, the mention of systemic illness in the draft

98. Recruiting/Selecting Participants (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/delilberative-methods-design-goold.pdf
    May 29, 2025 - Recruiting/Selecting Participants Slide 10 Recruiting/Selecting Participants Susan Dorr Goold, MD, MHSA, MA Professor of Internal Medicine and Health Management and Policy University of Michigan Slide 11 Alternatives to Random Sampling  Substantive representation o Based on extent to which groups a…

99. Prostate-Cancer-Therapies-Update Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_executive.pdf
    December 01, 2014 - than in the WW group; the strength of evidence was moderate due to consistent and precise findings … than for the EBRT plus ADT group. … compared with 54% in the EBRT-alone group. … with 60% in the EBRT- alone group. … compared with the WW group.

100. Methods Future Research Needs Number 8: Framework for Considering Study Designs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
     March 01, 2012 - Interrupted time series (without a comparison group) D. Retrospective cohort study K. … Interrupted time series with comparison group L. Cross-sectional study F. … In this study design the study group receives the intervention or exposure and the comparison group … No comparison group is present, limiting its utility in CER. … with the outcomes of a control group that has received another intervention or placebo.